InfuSystem (NYSE:INFU) Upgraded at Sidoti

Sidoti upgraded shares of InfuSystem (NYSE:INFU) to a strong-buy rating in a report published on Tuesday morning,Zacks.com reports.

Separately, StockNews.com upgraded InfuSystem from a “buy” rating to a “strong-buy” rating in a report on Friday, March 14th.

InfuSystem Stock Performance

Shares of INFU opened at $5.65 on Tuesday. InfuSystem has a one year low of $5.29 and a one year high of $9.97. The company has a market cap of $118.70 million, a PE ratio of 94.18 and a beta of 1.75. The stock has a 50-day moving average of $7.47 and a 200-day moving average of $7.53. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

Hedge Funds Weigh In On InfuSystem

Several large investors have recently added to or reduced their stakes in the business. GSA Capital Partners LLP raised its stake in shares of InfuSystem by 23.9% in the third quarter. GSA Capital Partners LLP now owns 65,680 shares of the company’s stock worth $440,000 after purchasing an additional 12,657 shares during the last quarter. Oppenheimer Asset Management Inc. raised its position in InfuSystem by 28.0% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 33,337 shares of the company’s stock valued at $223,000 after buying an additional 7,295 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in InfuSystem during the 3rd quarter valued at $87,000. BNP Paribas Financial Markets boosted its holdings in InfuSystem by 66.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company’s stock worth $27,000 after acquiring an additional 1,626 shares during the last quarter. Finally, State Street Corp grew its stake in shares of InfuSystem by 1.1% in the 3rd quarter. State Street Corp now owns 267,012 shares of the company’s stock worth $1,789,000 after acquiring an additional 3,019 shares in the last quarter. Institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.